IOIBD

 INTERNATIONAL ORGANIZATION FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE

  Mission statement

The International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) is the only international worldwide organization devoted to these chronic and sometimes disabling diseases involving different parts of the gastrointestinal tract. The mission of the IOIBD is to promote knowledge and to stimulate improvement in the care of patients with IBD. This is in particular the case for those countries where the diseases are just evolving. Task forces of IOIBD promote scientific developments by designing non commercial clinical studies. Grants are provided for innovative startup projects and large scale trials not receiving funds otherwise due to lack of economic or political interest. Travel grants are given to young scientists from countries with evolving IBD.

The organization furthermore aims at developing clear definitions of the different manifestations of IBD as well as for the targets and endpoints of treatment in practice and research, in particular in clinical trials. By doing so IOIBD provides expert guidance to regulatory authorities and to companies developing drugs and technology in the field of IBD. This is in particular the case for the corporate members by the direct stimulating interaction between opinion leaders and company representatives at the annual meetings and beyond.

The long-term goal of IOIBD is to contribute to the elucidation of the cause of these still relatively new diseases and finally to the development of a causal and curative treatment, thereby making its existence unnecessary.